NEW ORLEANS, Aug. 17, 2018 /PRNewswire/ -- ClaimsFiler, a
FREE shareholder information service, reminds investors that they
have until September 17, 2018
to file lead plaintiff applications in a securities class action
lawsuit against ACADIA
Pharmaceuticals Inc. (NasdaqGS: ACAD), if they purchased the
Company's securities between April 29,
2016 and July 9, 2018,
inclusive (the "Class Period"). This action is pending in
the United States District Court
for the Southern District of California.
Get Help
ACADIA investors should visit
us at
https://www.claimsfiler.com/cases/view-acadia-pharmaceuticals-inc-securities-litigation-1
or call to speak to our claim center toll-free at (844)
367-9658.
About the Lawsuit
ACADIA and certain of its
executives are charged with failing to disclose material
information during the Class Period, violating federal securities
laws.
On July 9, 2018, a report
published by the Southern Investigative Reporting Foundation
highlighted problems associated with the Company's sole drug,
Nuplazid, a treatment for Parkinson's disease, as well as the
Company's growth strategies that "have attracted intense regulatory
scrutiny for other drug companies" including "dispensing wads of
cash to doctors to incentivize prescription writing and downplaying
mounting reports of patient deaths."
On this news, the price of ACADIA's shares plummeted $1.21/share, or 6.8%, to close at $16.63/share on July 9,
2018.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information
source to help retail investors recover their share of billions of
dollars from securities class action settlements. ClaimsFiler's
team of experts monitor the securities class action landscape and
cull information from a variety of sources to ensure comprehensive
coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View original
content:http://www.prnewswire.com/news-releases/acadia-pharmaceuticals-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-acadia-pharmaceuticals-inc---acad-300698976.html
SOURCE ClaimsFiler